维生素 D 检测市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

在预测期内，维生素 D 测试市场预计将以 5.1% 的复合年增长率增长。

COVID-19 大流行对 2020 年的维生素 D 检测市场产生了重大影响。 在大流行期间，严格的家庭隔离方案、推迟的选择性程序以及政府暗示的其他限制使人们难以进入医疗机构。 因此，包括维生素 D 测试在内的路由测试被推迟了。 例如，国家生物技术信息中心 (NCBI) 于 2022 年 9 月发表的一项名为“COVID-19 对儿童医疗中心实验室利用的影响”的研究发现，在大流行期间，实验室检测估计减少了 84%。报导。 这主要是由于 SARS-COV-2 病毒的实验室检测量激增，这大大抵消了其他适应症的诊断检测量，包括维生素 D 水平检测。

例如，根据 Informa UK Limited 于 2022 年 1 月发表的一篇文章，据报导，全球每年报告有 890 万例因骨质疏鬆症导致的骨折。 此外，根据哈雷街头髮移植诊所在 2022 年 11 月发表的一项研究，据报导英国有 1540 万人患有头髮稀疏问题。 这些相关疾病增加了检测体内维生素 D 水平的需求。 这反过来又增加了全球对多种维生素 D 检测试剂盒的需求，推动了市场增长。 与此同时，用于快速检测的先进产品的推出以及大公司采用的几种增长战略提高了公众对维生素 D 检测试剂盒的采用率。

例如，2022 年 11 月，2San 宣布了一种用于家庭检测的维生素 D 快速检测试剂盒，可在 10 分钟内提供结果。 2San 是世界领先的一流医疗设备、套件和感染控制系统的製造商和分销商之一。 公司在英国、澳大利亚、美国、加拿大等地拥有强大的供应炼网络。 同样在 2022 年 1 月，远程医疗和医疗设备公司 Empower Clinics Inc. 的子公司 MediSure Canada 从加拿大卫生部获得了 MediSure 维生素 D 快速检测的商业权利。 这使公司能够在研究期间满足对维生素 D 快速检测试剂盒不断增长的需求。 与此同时，政府和私人团体对维生素 D 缺乏症的认识不断提高，向公众传播了有关维生素 D 营养价值的知识，并提高了维生素 D 检测率。

例如，2022 年 1 月，Horlicks Women's Plus 与 Apollo Clinic 合作，以提高女性对骨骼健康的认识。 该宣传活动为印度钦奈阿波罗诊所的 30 多岁女性提供免费维生素 D 检测。 2022 年 5 月，英国政府还召开了一次会议，征求有关提高英国维生素 D 水平的意见。 本次电话会议的主要目的是提高公众对维生素 D 的认识，并通过饮食和膳食补充剂提高维生素 D 水平。 因此，普通大众对维生素 D 检测的需求和采用率猛增，推动了整体市场增长。

因此，上述因素帮助市场在研究期间显着增长。 然而，某些明显的优势，例如由于缺乏检测试剂盒的验证而导致的体内维生素 D 水平的错误检测，预计会阻碍市场增长。

维生素 D 测试市场趋势

25-羟基维生素 D 测试有望在研究期间主导市场

25-羟基维生素 D 测试被认为是检测人体维生素 D 水平的最准确方法。 根据西奈山伊坎医学院 2022 年 4 月发表的一篇文章，25-羟基维生素 D 测试被认为是确定体内维生素 D 水平的最准确方法。 此外，Healthline Media 于 2022 年 1 月发表的一篇文章指出，25 羟基维生素 D 的含量是检测骨质疏鬆症和佝偻病的重要指标。

此外，某些优势（例如 25OH 维生素 D 的保质期比 1,25 二羟基维生素 D 更长）有望在研究期间推动该细分市场的采用。 例如，根据 NCBI 2022 年 9 月的一篇文章，由于 25-羟基维生素 D 的半衰期长达两週，因此据报导主要推荐用于检测维生素 D 水平。

除此之外，增加久坐不动的生活方式、减少暴露在阳光下以及减少绿叶蔬菜和水果的摄入会降低人体内维生素 D 的含量。 例如，HealthifyMe 于 2022 年 6 月发表的一篇文章将阳光照射不足归因于几个因素，其中包括维生素 D 缺乏症的主要原因。 此外，根据 Informa UK Limited 于 2020 年在印度进行的一项横断面研究，据报导，肥胖患者维生素 D 缺乏症的患病率约为 65.5%。 因此，在研究期间，患有维生素 D 缺乏症的患者人数增加，并且采用 25-羟基维生素 D 检测的人数增加。

此外，用于 25-羟基维生素 D 检测的广泛产品组合增加了医生和公众对该检测试剂盒和检测技术的采用。 例如，2020 年 3 月，Thermo Fisher Scientific Inc. 宣布在美国推出用于 25-羟基维生素 D 测定测试的 Cascadion SM 临床分析仪。

北美有望主导维生素 D 检测市场

预计将主导北美市场的关键因素包括维生素 D 缺乏症患病率的上升以及美国 FDA 批准的维生素 D 检测试剂盒产品数量的增加。 例如，根据克利夫兰诊所 2022 年 8 月发布的数据，估计美国有 35% 的成年人患有维生素 D 缺乏症。 这将增加该地区对诊断试剂盒的需求和采用，并在研究期间推动该地区的增长。

此外，一些组织正在美国开展宣传活动，以提高人们对维生素 D 营养价值的认识。 例如，2020 年 8 月，有机与天然健康协会发起了一项教育活动，以提高人们对维生素 D 的健康益处的认识。 这增加了普通人群对维生素 D 检测的需求和采用，随后支持了该地区市场的增长。

除此之外，针对某些维生素 D 检测的优惠报销政策以及公众对维生素 D 检测的认识不断提高，有望显着提高维生素 D 检测的采用率。我正在展示 根据 2022 年 4 月的 UnitedHealthcare Medicantage 政策指南，如果您的维生素 D 水平低于 20 ng/dl 或高于 60 ng/dl，您将在美国报销某些费用。

因此，由于上述因素，预计北美地区在预测期内将引领地区份额。

维生素 D 检测行业概况

维生素 D 检测市场本质上是整合的，一些主要参与者主导着市场份额。 竞争格局包括对具有市场份额的知名国际和本地公司的分析。 F. Hoffmann-La Roche Ltd、DiaSorin S.p.A.、Abbott、bioMerieux SA、Siemens Healthcare GmbH、Beckman Coulter, Inc. Quest Diagnostics Incorporated、Quidel Corporation、Thermo Fisher Scientific Inc. Tosoh Bioscience, Inc、Qualigen Therapeutics Inc. 包含。

其他福利：

• Excel 格式的市场预测 (ME) 表
• 3 个月的分析师支持

内容

第一章介绍

• 调查假设和市场定义
• 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

• 市场概览
• 市场驱动力
  • 维生素 D 缺乏症增加
  • 维生素D检测设备技术进展
  • 提高营利性和非营利性组织对维生素 D 缺乏症的认识
• 市场製约因素
  • 与维生素 D 检测相关的高成本
• 波特的五力分析
  • 新进入者的威胁
  • 买家/消费者的议价能力
  • 供应商的议价能力
  • 替代品的威胁
  • 竞争对手之间的竞争强度

第 5 章市场细分（按价值划分的市场规模）

• 按测试类型
  • 25-羟基维生素 D 测试
  • 1,25 二羟基维生素 D 测试
• 最终用户
  • 医院和诊所
  • 诊断实验室
  • 其他最终用户
• 地区
  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 韩国
    • 其他亚太地区
  • 中东和非洲
    • 海湾合作委员会
    • 南非
    • 其他中东和非洲地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲

第六章竞争格局

• 公司简介
  • F. Hoffmann-La Roche Ltd.
  • bioMerieux SA
  • Beckman Coulter, Inc.
  • DiaSorin S.p.A.
  • Siemens Healthcare GmbH
  • Quest Diagnostics Incorporated
  • Abbott
  • Quidel Corporation
  • Thermo Fisher Scientific Inc.
  • Tosoh Bioscience, Inc.
  • QUALIGEN THERAPEUTICS, INC.

第七章市场机会与未来趋势

The Vitamin D Testing Market is expected to register a CAGR of 5.1% over the forecast period.

The COVID-19 pandemicmoderately impacted the Vitamin D Testing Market in 2020. Stringent lockdown scenarios at home restrictions, postponement of elective procedures, and other restrictions implied by the government during the pandemic resulted in difficulties while accessing healthcare facilities. This subsequently delayed the routing testing procedures, including the vitamin D test. For instance, in a study, "The Impact of COVID-19 on Laboratory Test Utilization at a Pediatric Medical Center", published by the National Center for Biotechnology Information (NCBI) in September 2022, it was reported that an estimated 84% decrease in lab tests was observed during the pandemic. This was primarily owing to a surge in the lab test volume for the SARS-COV-2 virus, which dramatically offset the diagnostic testing volume for other indications, including the test for vitamin D level.

However, the increasing prevalence of several vitamin D deficiency-associated diseases such as osteoporosis, hair loss, excessive fatigue, and others are augmenting the demand for diagnostic testing of vitamin D. For instance, according to an article published by Informa UK Limited in January 2022, it was reported that globally 8.9 million fractures were reported in each year due to osteoporosis. Also, according to a study published by Harley Street Hair Transplant Clinics in November 2022, it was reported that 15.4 million people in the United Kingdom are suffering from hair loss. These associated disorders are increasing the demand to detect vitamin D levels in the body. This, in turn, is increasing the demand for several vitamin D testing kits globally and fostering the market's growth.

Along with this, the introduction of advanced products for rapid testing and the adoption of several growth strategies adopted by the key players are rising the adoption rate of vitamin D test kits among the common people. For instance, in November 2022, 2San introduced vitamin D rapid test kits for home testing, which offer results within 10 minutes. 2San is one of the leading global manufacturers and distributors of best-in-class medical devices, kits, and infection control systems across the globe. The company has a robust supply chain network in the United Kingdom, Australia, the United States, Canada, and others. Also, in January 2022, MediSure Canada, a subsidiary of Empower Clinics Inc., a telemedicine and medical device company, received the commercialization right from Health Canada for Medisure Vitamin D Rapid Test. This helped the company to cater to the rising demand for vitamin D rapid test kits during the study period. This is augmenting the preference for home test kits and subsequently resulting in the higher adoption of vitamin D tests.

Along with this, rising initiatives for awareness of vitamin D deficiency by the government and private organization is increasing the knowledge of the nutritious value of vitamin D among common people, which in turn increase the rate of vitamin D testing procedures. For instance, in January 2022, Horlicks Women's Plus partnered with Apollo Clinic to improve bone health awareness among women. In this awareness campaign, they offered free vitamin D tests for women of age group 30 years across Apollo clinics in Chennai, India. Also, the government of England arranged a conference in May 2022 to seek views on improving vitamin D levels among the England population. The main objective of this conference call was to improve population awareness of vitamin D, improving vitamin D levels through diet and dietary supplements. This is alternatively surging the demand and adoption of vitamin D tests among the general population and resulting in the market's overall growth.

Therefore, the aforementioned factors have been instrumental in the substantial growth of the market during the study period. However, certain distinct advantages, including false detection of vitamin D level in the body due to lack of validation of the testing kits, is anticipated to hinder the market growth.

Vitamin D Testing Market Trends

25-Hydroxy Vitamin D Test is Anticipated to Dominate the Market During the Study Period

25-hydroxy vitamin D test is considered the most accurate way to detect the level of vitamin D in a person. According to an article published by Icahn School of Medicine at Mount Sinai in April 2022, it was stated that 25-hydroxy vitamin D test is considered the most precise way to determine the vitamin D level in the body. Also, according to an article published by Healthline Media in January 2022, it was stated that the amount of 25 OH vitamin D is an important indicator to detect osteoporosis and rickets.

Additionally, certain benefits, including longer shelf life of 25 OH vitamin D over 1,25 dihydroxy vitamin D, are poised to fuel the adoption of this segment during the study period. For instance, according to an article by NCBI in September 2022, it was reported that owing to the extended half-life of 2 weeks for 25-hydroxy vitamin D, it is mostly recommended for the detection of vitamin D levels in the body as opposed to 1,25 dihydroxy vitamin D, which has a half-life of fewer than 4 hours.

Apart from that, an increasingly sedentary lifestyle decreases exposure to sunlight, and a lower intake of green vegetables and fruits results in a reduced amount of vitamin D in the human body. For instance, according to an article published by HealthifyMe in June 2022, it was stated that several factors, including the primary reason for vitamin D deficiency, is attributed to lack of exposure to sunlight. Also, according to a cross-sectional study conducted in India and published by Informa UK Limited in 2020, it was reported that the prevalence of vitamin D deficiency was found to be around 65.5% among obese patients. This resulted in an increased patient pool suffering from vitamin D deficiency disorders which in turn increased the adoption of the 25-hydroxy vitamin D test during the study period.

In addition to that, a wide range of product availability for the 25-hydroxy vitamin D test is augmenting the adoption rate of this test kit and assay technology among physicians and the general population. For instance, in March 2020, Thermo Fisher Scientific Inc. announced the availability of the Cascadion SM Clinical Analyzer in the United States for 25-hydroxy vitamin D assay testing.

Therefore, the reasons mentioned above are the primary driving factors for the lion's share of the segment in the market during the study period.

North America is Anticipated to Dominate the Vitamin D Testing Market

North America is expected to dominate the market owing to primary factors, including the rising prevalence of vitamin D deficiency and the rising number of product approvals for vitamin D test kits by the U.S. FDA in the United States. For instance, according to data published by Cleveland Clinic in August 2022, an estimated 35% of adults in the United States suffer from vitamin D deficiency. This augments the demand and adoption of diagnostic kits in this region and alternatively fuels regional growth during the study period.

Additionally, to increase awareness of the nutritional value of vitamin D, several organizations are organizing awareness campaigns in the United States. For instance, in August 2020, the Organic & Natural Health Association initiated an educational campaign to enlighten the health benefits of vitamin D. This increased the demand and adoption of vitamin D testing among the general population and subsequently supported the growth of the market in this region.

Apart from that, the availability of favorable reimbursement policies for certain vitamin D tests and increasing awareness among the general population on vitamin D tests is poised to increase the adoption of vitamin D tests in a large proportion. According to UnitedHealthcare Medicare Advantage Policy Guideline in April 2022, it was stated that if the vitamin D level is less than 20 ng/dl or greater than 60 ng/dl, a certain amount of the expense will be reimbursed in the United States.

Therefore, owing to the above-mentioned factors, the North America region is anticipated to lead the regional share during the forecast period.

Vitamin D Testing Industry Overview

The Vitamin D Testing Market is consolidated in nature due to the presence of a few major players dominating the market shares. The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well known. include F. Hoffmann-La Roche Ltd, DiaSorin S.p.A., Abbott, bioMerieux SA, Siemens Healthcare GmbH, Beckman Coulter, Inc., Quest Diagnostics Incorporated, Quidel Corporation, Thermo Fisher Scientific Inc., Tosoh Bioscience, Inc., Qualigen Therapeutics Inc., among others.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Growing Prevalence of Vitamin D Deficiency Diseases
  • 4.2.2 Technological Advancement in the Vitamin D Testing Devices
  • 4.2.3 Rising Awareness by the For Profit and Non-Profit Organisation for Vitamind D Deficiency
• 4.3 Market Restraints
  • 4.3.1 High Cost Associated with Vitamin D Testing
• 4.4 Porter's Five Forces Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

• 5.1 By Test Type
  • 5.1.1 25-Hydroxy Vitamin D Test
  • 5.1.2 1,25 Dihydroxy Vitamin D Test
• 5.2 By End-User
  • 5.2.1 Hospitals & Clinics
  • 5.2.2 Diagnostics Labs
  • 5.2.3 Other End-Users
• 5.3 Geography
  • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
  • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
  • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
  • 5.3.4 Middle-East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
  • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 F. Hoffmann-La Roche Ltd.
  • 6.1.2 bioMerieux SA
  • 6.1.3 Beckman Coulter, Inc.
  • 6.1.4 DiaSorin S.p.A.
  • 6.1.5 Siemens Healthcare GmbH
  • 6.1.6 Quest Diagnostics Incorporated
  • 6.1.7 Abbott
  • 6.1.8 Quidel Corporation
  • 6.1.9 Thermo Fisher Scientific Inc.
  • 6.1.10 Tosoh Bioscience, Inc.
  • 6.1.11 QUALIGEN THERAPEUTICS, INC.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS